Following a full day’s deliberations, a federal jury in Raleigh, North Carolina, returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation after a seven-day trial involving Aredia and Zometa, medicines used to prevent the devastating…
The U.S. District Court for the Western District of North Carolina granted a motion filed by Firm client Novartis Pharmaceuticals Corporation (“NPC”) to preclude punitive damages law in this case involving claims that the drugs Aredia…
After just over two hours of deliberation, an 11-person jury in the Western District of Kentucky (Bowling Green), returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation following a three-week trial. In Kyle v. Novartis…
The U.S. District Court for the District of Minnesota granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“Novartis”) on all “generics liability” claims in the pharmaceutical products liability case, Kruszka v. Novartis Pharm.…
Novartis Pharmaceuticals secured dismissal of punitive damages demands in the Middle District of Florida, joining the vast majority of other courts in the Aredia/Zometa litigation in holding that New Jersey law governs the question of punitive…
The U.S. District Court for the Eastern District of Washington granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s expert witnesses and then granted summary judgment in favor of Novartis in Luttrell v. Novartis Pharm.…
The Ninth Circuit affirmed the District Court’s award of summary judgment in favor of Novartis Pharmaceuticals Corporation (“Novartis”) in the pharmaceutical products liability case, Luttrell v. Novartis Pharm. Corp., No. 12-35893, 555 F. App’x 710 (9th…
Judge Graham Mullen ruled on Novartis’s Daubert motion in a Zometa case, excluding large portions of the opinions of Dr. Suzanne Parisian. Lemons v. Novartis Pharm. Corp., No. 3:08-cv-00361 (W.D.N.C. Order March 21, 2012). Dr. Parisian…
